儿科急诊就诊儿童中的社区获得性急性肾损伤
该回顾性横断面研究纳入某儿童医院儿科急诊2015年全年15,486例有肌酐检测的1月龄至18岁患儿,排除慢性肾脏病、终末期肾病及急诊死亡者,采用改良KDIGO肌酐标准对照年龄特异性正常值判定社区获得性急性肾损伤(CA-AKI)。CA-AKI发生率为239/15,486(1.5%);急诊医生识别46/239(19%),住院团队识别123/199(62%),急诊与住院医生均未识别74/199(37%)。正确诊断组年龄更大(13岁 vs 10岁,p=0.0114)、更多为2或3期AKI(OR=5.5,95%CI=2.6-11.8)、更可能被收住院(OR=10.3,95%CI=1.38-77.4)。作者认为CA-AKI在儿科急诊仍被低估,需要更好的早期识别工具。
要点
- 儿科急诊有肌酐检测的患儿中CA-AKI发生率为239/15,486(1.5%),急诊医生仅识别46/239(19%)。
- 住院的AKI患儿中住院团队识别123/199(62%),急诊与住院医生均未识别74/199(37%)。
- 正确诊断的AKI患儿更可能为2或3期(OR=5.5,95%CI=2.6-11.8)、更可能被收住院(OR=10.3,95%CI=1.38-77.4)。
- 正确诊断组年龄大于漏诊组(13岁 vs 10岁,p=0.0114)。
- 作者认为CA-AKI在繁忙儿科急诊中仍被低估,需要更好的早期识别工具。
适用人群与场景
- 某儿童医院儿科急诊2015年1月1日至12月31日就诊、年龄1月龄至18岁、至少检测一次肌酐的患儿。
- 排除慢性肾脏病、终末期肾病及在急诊死亡的患儿。
诊断标准与关键阈值
- 采用改良肾脏病改善全球结局(KDIGO)标准,以急诊检测的肌酐与年龄特异性正常值比较判定社区获得性急性肾损伤。
- 由儿科急诊医生作出AKI诊断者视为被识别。
研究设计与关键结果
- 回顾性横断面研究,2015年儿科急诊共119,151次就诊,15,486次符合纳入标准。
- CA-AKI见于239/15,486(1.5%)次就诊。
- 急诊医生识别AKI 46/239(19%);住院团队识别123/199(62%)住院AKI患儿;急诊与住院医生均未识别74/199(37%)。
- 正确诊断组年龄13岁 vs 漏诊组10岁(p=0.0114)。
- 正确诊断组更多为2或3期AKI(OR=5.5,95%CI=2.6-11.8)。
- 正确诊断组更可能被收住院(OR=10.3,95%CI=1.38-77.4)。
证据类型、等级与局限
- 证据类型:回顾性横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CA-AKI在儿科急诊仍是被低估的临床问题,需要更好的早期识别工具,以利于采取肾脏保护措施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute kidney injury (AKI) is a significant risk factor for morbidity and mortality in children. Little is known about community-acquired AKI (CA-AKI) in the pediatric emergency department (PED). Early recognition of AKI allows for nephroprotective measures. The goal of this investigation was to determine the incidence of CA-AKI and the frequency of clinician identified CA-AKI to better inform future nephroprotective interventions.
METHODS: This was a retrospective cross-sectional study in the PED of a children's hospital. Children 1 month to 18 years of age seen in the PED from January 1 to December 31, 2015, and in whom at least one creatinine level was obtained were included. Patients with chronic kidney disease or end-stage renal disease or who died in the PED were excluded. Patients had CA-AKI based on modified Kidney Disease-Improving Global Outcomes criteria using the creatinine obtained in the PED compared to age-specific norms. Patients were considered identified if the PED clinician diagnosed AKI. The primary outcome was the incidence of CA-AKI. Secondary outcomes included frequency of AKI identification, nephrotoxic medication use, hospital length of stay, renal replacement therapy, and death. Fisher exact test or Pearson's chi-square test was used to calculate odds ratio (OR) with 95% confidence intervals (CIs); multivariable analyses were performed using logistic regression.
RESULTS: In 2015 there were 119,151 PED visits; 15,486 met inclusion criteria. CA-AKI was present in 239 of 15,486 (1.5%) encounters. AKI was identified by PED clinicians in 46 of 239 (19%) of encounters and by the inpatient team in 123 of 199 (62%) of the encounters admitted. AKI was never recognized by a PED or inpatient clinician in 74 of 199 (37%) encounters. Encounters with AKI correctly diagnosed were older (13 years old vs. 10 years old, p = 0.0114), had more severe (stage 2 or 3) AKI (OR = 5.5, 95% CI = 2.6-11.8), and were more likely to be admitted (OR = 10.3, 95% CI = 1.38-77.4) than encounters with missed AKI.
CONCLUSIONS: CA-AKI remains an underrecognized entity in the PED. Better tools for early recognition of AKI in the busy PED environment are needed.
参考来源
- Bernardo EO, Cruz AT, Buffone GJ, et al. Community-acquired Acute Kidney Injury Among Children Seen in the Pediatric Emergency Department. Acad Emerg Med. 2018. PMID: 29630763. doi:10.1111/acem.13421
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。